Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U7 small nuclear 179 pseudogene (RNU7-179P) is classified as a non-coding RNA pseudogene derived from the U7 small nuclear RNA gene family. The parental gene, U7 snRNA, is a component of the U7 small nuclear ribonucleoprotein complex (U7 snRNP), which is critical for histone pre-mRNA 3' end processing in metazoan cells[1][3][5]. Pseudogenes such as RNU7-179P typically arise via gene duplication or retrotransposition events and accumulate mutations rendering them non-functional in terms of their original gene product[7][8]. Most pseudogenes, including RNU7-179P, do not produce functional molecules nor are they considered direct drug targets[8]. Occasionally, some pseudogenes can act as regulatory RNA molecules, but no specific biological or clinical function has been described for RNU7-179P. There are no known drugs, biomarkers, or therapeutic roles associated with this pseudogene. Summary of rationale: - The “RNA, U7 small nuclear 179 pseudogene” is a processed pseudogene (non-functional copy) of the U7 snRNA gene family[3][7]. - U7 snRNA plays a well-established role in histone pre-mRNA processing, but pseudogenes like RNU7-179P do not encode functional RNAs or proteins and are not considered therapeutic targets[1][8]. - No evidence of direct disease association, therapeutic relevance, or drug interactions was found for RNU7-179P. - This entry is not a misspelling or incorrect but is a relevant example of a non-coding RNA pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 179 pseudogene (RNU7-179P).